Rabbit, a relevant model for the study of cardiac β3- adrenoceptors

Experimental Physiology

Volumn 94, Issue 4, 2009, Pages 400-411

  Audigane, Leslie ^a,b,c   Kerfant, Benoît Gilles ^a,b,d,e   El Harchi, Aziza ^a,b,d,f   Lorenzen Schmidt, Ilka ^a,b,d   Toumaniantz, Gilles ^a,b,d   Cantereau, Anne ^b   Potreau, Daniel ^b   Charpentier, Flavien ^a,b,d   Noireaud, Jacques ^a,b,d,g   Gauthier, Chantal ^a,b,d,e  

^a L INSTITUT DU THORAX   (France)

^b CNRS   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e INSERM   (France)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UPSP 5304 Laboratoire de Physiopathologie animale et de Pharmacologie fonctionnelle   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; ISOPRENALINE; MESSENGER RNA; NADOLOL; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; MALE; NONHUMAN; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

EID: 62449131309     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2008.045179     Document Type: Article

References (35)

1. 3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 107, 452 460.
2. 3-adrenoceptor activation and the involvement of nitric oxide. J Card Surg 17, 465 469.
3. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 142, 567 575.
4. Baudet S, Weisser J, Janssen AP, Beulich K, Bieligk U, Pieske B, Noireaud J, Janssen PM, Hasenfuss G Prestle J (2001). Increased basal contractility of cardiomyocytes overexpressing protein kinase Cε and blunted positive inotropic response to endothelin-1. Cardiovasc Res 50, 486 494.
5. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415, 198 205.
6. Ks in guinea pig ventricular myocytes. Cardiovasc Res 56, 393 403.
7. 3-adrenoceptor-induced ENOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol 143, 1014 1022.
8. Brutsaert DL (2003). Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83, 59 115.
9. 3- adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23, 1057 1065.
10. 3-adrenergic receptor in the failing canine myocardium. Circ Res 89, 599 606.
11. + current: a potential mechanism of the proarrhythmic effects of methanesulfonanilide class III agents. Cardiovasc Res 43, 135 147.
12. Chomczynski P Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156 159.
13. Cuniberti LA, Stutzbach PG, Guevara E, Yannarelli GG, Laguens RP Favaloro RR (2006). Development of mild aortic valve stenosis in a rabbit model of hypertension. J Am Coll Cardiol 47, 2303 2309.
14. 3-adrenoreceptors in rat hearts. Diabetes 50, 455 461.
15. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102, 1377 1384.
16. 3-adrenoceptor in the human heart. J Clin Invest 98, 556 562.
17. 3-adrenoceptor agonists. J Pharmacol Exp Ther 290, 687 693.
18. 3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes. J Pharmacol Exp Ther 316, 392 402.
19. Hasenfuss G (1998). Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39, 60 76.
20. 1-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedeberg's Arch Pharmacol 368, 496 503.
21. 3-adrenoreceptors to the KvLQT1/MinK potassium channel. J Biol Chem 275, 26743 26747.
22. Kaumann AJ Molenaar P (1997). Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn Schmiedeberg's Arch Pharmacol 355, 667 681.
23. Kerfant BG, Gidrewicz D, Sun H, Oudit GY, Penninger JM Backx PH (2005). Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kγ-deficient mice. Circ Res 96, 1079 1086.
24. 3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol 35, 786 790.
25. Lands AM, Luduena FP Buzzo HJ (1967). Differentiation of receptors responsive to isoproterenol. Life Sci 6, 2241 2249.
26. Maurice JP, Shah AS, Kypson AP, Hata JA, White DC, Glower DD Koch WJ (1999). Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol Heart Circ Physiol 276, H1853 H1860.
27. 4-adrenoceptor' in mammalian heart. Clin Exp Pharmacol Physiol 24, 647 656.
28. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103, 1649 1655.
29. 3-adrenoceptors in human atrial myocardium. Br J Pharmacol 138, 521 529.
30. 3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111, 652 673.
31. Schulz R, Rassaf T, Massion PB, Kelm M Balligand JL (2005). Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol Ther 108, 225 256.
32. 2+ current. J Clin Invest 118, 3219 3227.
33. 2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 163, 362 367.
34. 3-adrenergic receptor. Cardiovasc Res 59, 288 296.
35. 3- adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 315, 1203 1211.